Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Letters   |    
Challenges in Diagnosing and Adequately Treating Malignant Catatonia and Its Fatal Consequences
Erol Ozan, M.D.; Esat Fahri Aydin, M.D.
The Journal of Neuropsychiatry and Clinical Neurosciences 2014;26:E52. doi:10.1176/appi.neuropsych.13030056
View Author and Article Information

Celal Bayar University School of Medicine Department of Psychiatry, Türkiye

Atatürk University School of Medicine Department of Psychiatry, Türkiye

Correspondence: Dr. Ozan; e-mail: erolozan@gmail.com

Copyright © 2014 by the American Psychiatric Association


To the Editor: Catatonia may often present with puzzling symptoms and etiologies that can delay adequate and timely treatment, increasing the risk of mortality.1 When accompanied with hyperthermia and autonomic instability, it is called malignant catatonia (MC).1,2 When preceded by antipsychotic use, catatonia is usually termed and treated as neuroleptic malignant syndrome (NMS), which is regarded as a variant of MC.1,3 The case below inspired us to highlight the challenges in diagnosing and adequately treating MC and its fatal consequences.

Figures in this Article

First Page Preview

View Large
First page PDF preview
Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).



Detweiler  MB;  Mehra  A;  Rowell  T  et al:  Delirious mania and malignant catatonia: a report of three cases and review.  Psychiatr Q 2009; 80:23–40
[CrossRef] | [PubMed]
Daniels  J:  Catatonia: clinical aspects and neurobiological correlates.  J Neuropsychiatry Clin Neurosci 2009; 21:371–380
[CrossRef] | [PubMed]
Fink  M;  Taylor  MA:  Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia.  Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:1182–1183; author reply 1184–1185
[CrossRef] | [PubMed]
Fink  M:  Delirious mania.  Bipolar Disord 1999; 1:54–60
[CrossRef] | [PubMed]
Narayanaswamy  JC;  Tibrewal  P;  Zutshi  A  et al:  Clinical predictors of response to treatment in catatonia.  Gen Hosp Psychiatry 2012; 34:312–316
[CrossRef] | [PubMed]
References Container

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content
DSM-5™ Clinical Cases > Chapter 2.  >
DSM-5™ Clinical Cases > Chapter 3.  >
DSM-5™ Clinical Cases > Chapter 3.  >
DSM-5™ Clinical Cases > Chapter 3.  >
DSM-5™ Clinical Cases > Chapter 4.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
PubMed Articles